(Q52592646)

4 May 2018

title

The safety and efficacy of immunotherapy with aluminum hydroxide-adsorbed venom extract of Vespula spp. An open, retrospective study. (English)

1 reference

4 May 2018

0 references

1 reference

Poli F

1

1 reference

4 May 2018

Longo G

series ordinal

2

1 reference

4 May 2018

Parmiani S

series ordinal

3

1 reference

4 May 2018

publication date

1 September 2001

1 reference

4 May 2018

Allergologia et Immunopathologia

published in

1 reference

4 May 2018

volume

29

1 reference

4 May 2018

issue

5

1 reference

4 May 2018

page(s)

191-196

1 reference

4 May 2018

A metabolizable adjuvant: clinical trial of grass pollen-tyrosine adsorbate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

A controlled trial of immunotherapy in insect hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Dose dependence of Hymenoptera venom immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Diagnosis and treatment of insect sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Combination of passive and active immunization in honeybee venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Rush venom immunotherapy program for honeybee sting sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

The Hymenoptera venom study. III: Safety of venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Hymenoptera venom hypersensitivity: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Safety of Hymenoptera venom rush immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Prolonged maintenance interval in hymenoptera venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

Stinging insect allergy: natural history and modification with venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

A case for venom treatment in anaphylactic sensitivity to hymenoptera sting.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979054-4

7 January 2021

10.1016/S0301-0546(01)79054-4

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018